These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17317613)

  • 1. Autoantibody response against a novel testicular antigen protein highly expressed in testis (PHET) in SSc patients.
    Yasuoka H; Kuwana M
    Autoimmun Rev; 2007 Mar; 6(4):228-31. PubMed ID: 17317613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies.
    Yasuoka H; Ihn H; Medsger TA; Hirakata M; Kawakami Y; Ikeda Y; Kuwana M
    J Immunol; 2003 Dec; 171(12):6883-90. PubMed ID: 14662895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.
    Fukasawa C; Kawaguchi Y; Harigai M; Sugiura T; Takagi K; Kawamoto M; Hara M; Kamatani N
    Eur J Immunol; 2003 Oct; 33(10):2792-800. PubMed ID: 14515263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
    Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
    Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.
    Del Galdo F; Maul GG; Jiménez SA; Artlett CM
    Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.
    Kawaguchi Y; McCarthy SA; Watkins SC; Wright TM
    J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis.
    Kowal-Bielecka O; Distler O; Neidhart M; Künzler P; Rethage J; Nawrath M; Carossino A; Pap T; Müller-Ladner U; Michel BA; Sierakowski S; Matucci-Cerinic M; Gay RE; Gay S
    Arthritis Rheum; 2001 Aug; 44(8):1865-75. PubMed ID: 11508440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display.
    Meyringer R; Neumann E; Judex M; Landthaler M; Kullmann F; Scholmerich J; Gay S; Tarner IH; Distler O; Müller-Ladner U
    J Rheumatol; 2007 Apr; 34(4):747-53. PubMed ID: 17407232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
    Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
    Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
    Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I.
    Reimand K; Perheentupa J; Link M; Krohn K; Peterson P; Uibo R
    Int Immunol; 2008 Jan; 20(1):39-44. PubMed ID: 18000009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
    J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.